Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Cuttsy + Cuttsy

Website
Email
+44 (0) 1223 967222

We are the original patient communications agency specialising in clinical trial engagement and healthcare communications for patients and HCPs.

We invested in the importance of patient engagement and centricity in communications many years ago because our insights told us we were onto something. It’s something we still live by today, investing in ways that we can embed and work with new and cutting-edge AI technologies, rather than against them.

Because powerful tools, when teamed with the human touch, can strike very loud and lasting chords with your target audience.

Unit 6, The Works, Unity Campus, London Road, Pampisford, Cambridge, CB22 3EE, United Kingdom

We are clinical trial engagement and education specialists.

The work we do supports clinical trial recruitment and retention by employing channel agnostic strategies and communications that cut through the complex.

Because when simplified and easy-to-understand content is the norm, HCPs feel supported, more patients are recruited, and engagement levels remain high all round.

We are leaders in healthcare communications.

We pioneered co-creation, embedded emotional intelligence in our processes and were the first to author disease awareness books combining health literacy, design principles and data visualisation.

Because when healthcare communication challenges can be solved creatively and collaboratively, we’re truly able to make a difference to the lives of healthcare professionals, patients, and their families and carers.

Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning

Cuttsy+Cuttsy proudly announces the expansion of its team with the addition of three new hires—Michelle, Jay, and Emily—and the welcome return of former team member Sally as Account Director.

AI and away we go: key insights from Reuters Pharma 2025

AI is revolutionising the pharmaceutical industry, as highlighted at Reuters Pharma 2025, with transformative applications across marketing, drug discovery, and patient engagement, despite challenges in adoption, regulation, and data trust.

Exciting updates from our content and strategy team

Cuttsy+Cuttsy celebrates new beginnings with the appointment of Oli Bailey as Strategy Director and recognises team excellence through several well-deserved promotions.

Cuttsy+Cuttsy launches ccura: AI powered, always human

Cuttsy+Cuttsy introduces ccura, an AI-powered healthcare communications platform that blends technology with human expertise to enhance collaboration, streamline workflows, and deliver patient-focused, high-quality solutions with security and compliance at its...

Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People

Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.

Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating

Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering...

How to boost clinical trial access and make patients health-empowered

Clinical research is becoming more patient-centric, but there's still more that needs to be done to make clinical trials available to everyone. This could include wider participation.

New report now available: Integrating ‘patient first’ into medicine development

A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...

Another year, another B!

Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

ALL PRESS RELEASES

A seat at the table: what the EU HTA reforms really ask of patient involvement

The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.

Why faster trials make participant understanding more important than ever

As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.

Older trial participants reject bad design, not technology

Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.

5 key takeaways from the Patient Centricity and Engagement Conference

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.

It’s time to stop calling adverse events ‘manageable’

A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.

The value: why localisation pays off across global trials

Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.

The solution: Good localisation doesn’t feel translated

Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.

Healthcare information is becoming easier to access. Trust isn’t.

Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.

It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment

ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.

Where translation falls short in practice

Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.

ALL WHITE PAPERS

Clinical trials, Actually.

This Christmas, we’re thinking of the thousands of clinical trial volunteers across the UK, both patients and healthy participants. We have a lot to thank them for...

Season’s Greetings

Do you have Tinsilitus?

Patient Engagement for the Life Sciences

Patient Engagement for the Life Sciences, written by Guy Yeoman and Mitchell Silva with editorial and design support from Cuttsy+Cuttsy, explains the ‘why’ and the ‘how’ of patient engagement. It...

Patient engagement changes people’s lives…

Find out how one family’s experience of CF led to the development of a game which made essential physio a positive experience for everyone involved.

Health Literacy Explained

Hear from Dr Elizabeth Walder, author of a series of patient-focused e-books in plain english and why health literacy is so important.

ALL VIDEOS AND PODCASTS

Doing the right thing has never been so important as it is right now.

At Cuttsy+Cuttsy we understand that sustainability goes further than just a responsibility to the planet, it’s a collective responsibility built upon environmental, social, and governance standards (ESG) across our entire portfolio. Following our first ‘Silver’ rating, we continually track and improve on our ESG commitments with EcoVadis, a sustainability ratings provider who partner with companies to supply a globally recognised scorecard and performance improvement tools.

As a company who believe that people and their world matters, we are serious about tackling climate change. We have committed to becoming a net zero agency. We will achieve this through accurate carbon disclosures with CDP (Carbon Disclosure Protocol) and verifiable science-based targets with SBTi (Science Based Targets initiative).

Please note – you must be logged in to X in this browser in order to see this Twitter / X Feed

Company Details

Cuttsy and Cuttsy Logo

Email
Website

 Latest Content from  Cuttsy + Cuttsy 

A seat at the table: what the EU HTA reforms really ask of patient involvement

The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.

Why faster trials make participant understanding more important than ever

As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.

Older trial participants reject bad design, not technology

Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.

5 key takeaways from the Patient Centricity and Engagement Conference

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.

It’s time to stop calling adverse events ‘manageable’

A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.

The value: why localisation pays off across global trials

Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.

The solution: Good localisation doesn’t feel translated

Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.

Healthcare information is becoming easier to access. Trust isn’t.

Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.

It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment

ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.

Where translation falls short in practice

Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.